Streetbeat News

Stock Prices

SPY

The USA Redbook year-over-year growth rate increased to 5.4% from the previous 5.3%, indicating a slight improvement in retail sales performance.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 1:10 pm

AMN

MRNA

NKTX

The article highlights three oversold healthcare stocks with potential for recovery: Nkarta Inc (NKTX), Moderna Inc (MRNA), and AMN Healthcare Services (AMN). Nkarta reported strong Q2 results but saw a 35% stock decline. Moderna initiated a Phase 3 trial for a norovirus vaccine, yet its stock fell 23%. AMN Healthcare was downgraded by B of A Securities, leading to a 15% stock drop.

Portfolio Pulse from Avi Kapoor

October 08, 2024 | 1:07 pm

WW

WW shares rose following the announcement that the company will include compounded semaglutide in its offerings.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 1:05 pm

KA

Kineta has completed enrollment in the monotherapy arm of its VISTA-101 Phase 1 clinical study for advanced solid tumors. This marks a significant milestone in the development of their cancer treatment.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 1:03 pm

DY

Dycom Industries (NYSE:DY) has received a range of analyst ratings, with most being bullish. Analysts have raised their price targets, with an average target of $207.8, up from $196.60. The company shows strong financial performance with high revenue growth and profitability, but has a higher debt-to-equity ratio than industry averages.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 1:00 pm

GRPN

Four analysts have recently assessed Groupon (NASDAQ:GRPN), with ratings ranging from bullish to bearish. The average 12-month price target is $23.5, down from $24.5. Groupon faces financial challenges, including a decline in revenue and profitability metrics below industry averages.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 1:00 pm

ALB

Albemarle (NYSE:ALB), a major lithium producer, has been analyzed by 16 analysts, showing a range of sentiments from bullish to bearish. Recent analyst actions include several downgrades and lowered price targets, reflecting concerns over Albemarle's financial performance, including a significant revenue decline and below-average profitability metrics. The average 12-month price target has decreased by 21.18%.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 1:00 pm

RBLX

Roblox shares are experiencing a decline following a short report issued by Hindenburg Research.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 12:58 pm